Fig. 2From: Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trialThe schedule of enrolment, interventions, and assessments. *GAI: Global Assessment of Improvement; §IBS: Irritable Bowel Syndrome; †TCM: Traditional Chinese Medicine; ‡IBS-QoL: Irritable Bowel Syndrome-Quality of Life; IBS-SSS**: Irritable Bowel Syndrome-Symptom Severity ScoreBack to article page